Renasant Bio News and Activities

Acquisition, funding and merger involving Renasant Bio.

• Renasant Bio has just announced a $54 Million fundraising (posted on July 15 2025).

View the org chart displaying its 10 main executives

Most searched biographies at Renasant Bio

• Emily Conley, Chief Executive Officer
• Kevin Bittermann, Director
• Anna French, Director

Create your alert
to follow the executive moves at Renasant Bio.

Renasant Bio has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Renasant Bio

Social media about Renasant Bio

• Renasant Bio on Wikipedia, Google News & Yahoo Finance
• Renasant Bio on LinkedIn, X (Twitter) & YouTube